The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects

Inclusion Criteria: * Able to comprehend and sign the ICF voluntarily prior to initiate the study; * Able to complete the study according to the protocol; * Between 18 and 45 years of age（18 and 45 are inclusive）; * Body weight of male and female subject should be ≥50 kg and ≥45 kg respectively; Body Mass Index (BMI) is between 18 and 28 kg/m2（18 and 28 are inclusive）; * Physical examination and vital signs without clinically significant abnormalities. Exclusion Criteria: * Smokers, who smoke more than 5 cigarettes/day within 3 months before the study; * Drink frequently, namely alcohol consumption are 14 units per week (1 unit = 285 mL of beer, or 25 mL of strong wine, or 100 mL of grape wine); * Donated blood or massive blood loss within 3 months before screening (\>450 mL）; * Have any disease that increases the risk of bleeding, such as acne, acute gastritis or stomach and duodenal ulcers; * Have take any drug that changes liver enzyme activity within 1 month before taking the study drug * Have taken any prescription drug, over-the-counter drug, vitamin product or herbal medicine within 14 days prior to screening; * Have participated in any clinical trial or taken any study drug within 3 months before dosing; * Viral hepatitis（including CHB and CHC）and positive test result of anti-HIV Ab or syphilis. * Have taken any alcoholic products within 24 hours prior to taking the study drug